Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE
If the Covid era marked a boom time for digital health companies, 2024 was the reckoning. In a year that saw the Nasdaq jump 32%, surpassing 20,000 for the first time this month, health tech providers largely suffered. Of 39 public digital health companies analyzed by CNBC, roughly two-thirds are down for the year. Others are now out of business. There were some breakout stars, like Hims & Hers Health , which was buoyed by the success of its popular new weight loss offering and its position in the GLP-1 craze. But that was an exception. While there were some company-specific challenges in the industry, overall it was a
Digital health stocks pummeled by Wall Street in 2024, but Hims surges
